Dr. Joshua Socolow FACC

Bio: Dr. Socolow works as a cardiologist in New York City and is a Fellow of the American College of Cardiology. Through his knowledge of cardiology, he has correctly predicted the acquisitions of Esperion (Pfizer), Amylin (Bristol Myers) and Imclone (Bristol Myers). Dr. Socolow has also maintained long term investments in Novo Nordisk, Novartis, Sanofi, Gilead, Boston Scientific and Amarin. MD, Wash U; BS, Yale.